HealthcareServices

Ventral Hernia Treatment Market Outlook: Growth and Forecast Highlights 2030

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ventral hernia treatment market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Ventral Hernia Treatment Market expected to grow between 2026 and 2030?

The ventral hernia treatment market has shown significant growth over recent years. It is anticipated to expand from $5.22 billion in 2025 to $5.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historical expansion can be linked to an increasing occurrence of abdominal hernias, higher rates of surgical interventions, the broader adoption of laparoscopic surgery, the increasing availability of surgical mesh products, and enhanced use of diagnostic imaging.

The ventral hernia treatment market is projected to experience robust expansion over the coming years, anticipated to reach a valuation of $7.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. Several factors will drive this growth during the forecast period, including the wider uptake of robotic surgery platforms, a heightened demand for tension-free repair methods, the proliferation of ambulatory surgical centers, an intensified focus on lowering hernia recurrence rates, and increased capital expenditure in cutting-edge surgical technologies. Key trends anticipated within this period encompass the growing acceptance of robotic-assisted hernia repair, the escalating utilization of sophisticated hernia mesh materials, a stronger inclination towards minimally invasive surgical techniques, the broader availability of day-care surgical options, and enhanced post-operative recovery protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

Which Drivers Are Influencing Market Acceleration In The Ventral Hernia Treatment Market?

The growing occurrence of obesity is projected to stimulate the expansion of the ventral hernia treatment market moving forward. Obesity is a medical condition defined by an excessive accumulation of body fat that significantly impairs an individual’s health. The increasing prevalence of obesity can be attributed to factors such as poor diet, a sedentary lifestyle, genetic predispositions, insufficient physical activity, environmental influences, and emotional stress. Ventral hernia treatment offers support to patients with obesity by addressing complications stemming from excess weight; it helps relieve strain on the abdominal wall, reduces the chance of hernia recurrence, and strengthens overall abdominal integrity, which is vital for enhancing mobility and encouraging healthier lifestyle choices for individuals grappling with obesity. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, disclosed that roughly one in eight people worldwide were struggling with obesity. This data included 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of them living with obesity. Among the adult population, 43% were overweight, and 16% were categorized as obese. Additionally, the number of overweight children under the age of 5 reached 37 million. Hence, the rising prevalence of obesity is a key driver for the ventral hernia treatment market.

What Segments Are Identified Within The Structure Of The Ventral Hernia Treatment Market?

The ventral hernia treatment market covered in this report is segmented –

1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia

2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)

3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery

4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics

Subsegments:

1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia

2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia

3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia

Which Innovation Trends Are Advancing Developments Within The Ventral Hernia Treatment Market?

Leading companies in the ventral hernia treatment market are prioritizing technological advancements, particularly in laparoscopic and open hernia mesh fixation devices, to enhance surgical outcomes, minimize complications, and improve patient recovery. These devices are medical tools employed to secure mesh during hernia repair surgeries, utilizing either minimally invasive (laparoscopic) or conventional open surgical techniques. For example, in March 2024, TELA Bio Inc., a US-based medical technology company, introduced the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. LIQUIFIX FIX8 is designed for minimally invasive repairs, while LIQUIFIX precision is intended for open femoral and inguinal hernia repairs. These FDA-approved devices incorporate liquid anchors to secure mesh without tissue penetration, thereby reducing trauma and potential complications. Given that over 1.2 million hernia procedures are performed annually in the U.S., LIQUIFIX offers both precision and safety in sensitive anatomical areas, simultaneously lowering the risks of vascular or nerve injury.

Which Major Industry Participants Are Leading The Ventral Hernia Treatment Market Growth?

Major companies operating in the ventral hernia treatment market are Johnson & Johnson Services Inc., Medtronic Plc, Becton, Dickinson and Company (BD), Braun Melsungen AG, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc, KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

Which Region Is Projected To Lead The Ventral Hernia Treatment Market During The Forecast Period?

North America was the largest region in the ventral hernia treatment market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Ventral Hernia Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21315&type=smp

Browse Through More Reports Similar to the Global Ventral Hernia Treatment Market 2026, By The Business Research Company

Sarcopenia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Hernia Mesh Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hernia-mesh-devices-global-market-report

Congenital Diaphragmatic Hernia Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/congenital-diaphragmatic-hernia-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795